Yu Xia is an associate in the Corporate Practice Group in the firm's Shanghai office.

Areas of Practice

Yu practices in the areas of private equity, mergers and acquisitions, foreign direct investment, and general corporate and business law. Yu has represented both international and Chinese clients in various projects, including their offshore PE investment, cross-border M&A, establishment of Joint Venture of China, as well as providing general legal advices in relation to taxation, labor and intellectual property.

Prior to joining Sheppard Mullin, Yu worked in a leading Chinese law firm.



Representative Matters

  • Represented a HK listed pharmaceutical company in its Series A-1 investment in a US based pharmaceutical corporation
  • Represented a HK listed pharmaceutical company in its Series A investment in a UK drug manufacturer
  • Represented a venture capital firm in its Series B investment in a China based online education company
  • Represented a Chinese PE fund in its Series A investment in a China based semiconductor company
  • Assisted a HK listed medical device company in establishing a joint venture with a leading European cardiac rhythm management device manufacturer in Shanghai
  • Assisted a Greek company in its acquisition of a mining company in Liaoning Province
  • Acted as the seller's counsel for a European PE fund in disposing its portfolio companies in China



New York Bar Association

Member of All-China Bar Association


J.D., The Ohio State University

LL.B., East China University of Political Science and Law


  • New York
  • PRC


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.